Lv1
78 积分 2023-11-24 加入
Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
2个月前
已完结
Transitioning from NAFLD to MAFLD and MASLD: Consistent prevalence and risk factors in a Chinese cohort
2个月前
已完结
Steatotic liver disease
2个月前
已完结
MAFLD as part of systemic metabolic dysregulation
2个月前
已完结
MAFLD: a multisystem disease
2个月前
已完结
Role of mitochondrial alterations in human cancer progression and cancer immunity
4个月前
已完结
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
4个月前
已完结
Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism
4个月前
已完结
Hypocrellin A against Intrahepatic Cholangiocarcinoma via Multi-Target Inhibition of the PI3K-AKT-mTOR, MAPK, and STAT3 Signaling Pathways
8个月前
已完结
Fibrosis: cross-organ biology and pathways to development of innovative drugs
8个月前
已完结
皖公网安备34019202002308
